Long-acting formulations of insulin

US9345750B2 · kind B2 · utility

Assignee

• Sanofi · FR

Inventors

• Reinhard Becker · Wiesbaden, DE
• Annke Hahn · Frankfurt am Main, DE
• Peter Boderke · Schwalbach, DE
• Christiane Fuerst · Frankfurt am Main, DE
• Werner Mueller · Cologne, DE
• Ulrich Werner · Frankfurt am Main, DE

Key dates

• Filing date: Mar 20, 2014
• Grant date: May 24, 2016
• Expiry date: Mar 20, 2034

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P5/50
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.